The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.

@article{Dimitroulopoulos2002TheRO,
  title={The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.},
  author={Dimitrios A Dimitroulopoulos and Dimitrios N Xinopoulos and Klisthenis Tsamakidis and Athanassios Zisimopoulos and Efthimios Andriotis and Sofia Markidou and Demosthenes P Panagiotakos and Christina A Chrysohoou and Athanassios Bazinis and Emmanuel Paraskevas},
  journal={Hepato-gastroenterology},
  year={2002},
  volume={49 47},
  pages={1245-50}
}
BACKGROUND/AIMS The overexpression of somatostatin receptors in the liver of some patients with hepatocellular carcinoma is well documented. The daily administration of octreotide in patients with advanced hepatocellular carcinoma was shown to have a marginal clinical effectiveness. The aim of the study was to estimate if and to what extent the administration of octreotide long-acting formulation (Sandostatin LAR) improves survival and quality of life in patients with advanced unresectable… CONTINUE READING
18 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…